ArticleCell metabolism2019

Inhibiting Glutamine-Dependent mTORC1 Activation Ameliorates Liver Cancers Driven by β-Catenin Mutations.

Adeola O Adebayo Michael et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.